Clinical Trial

Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

Study acronym: iPath Pilot
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-08
notable Primary completion pushed: 2025-06-30 -> 2026-07-31 2026-08-08
minor Completion pushed: 2025-12-15 -> 2026-08-31 2026-08-08
Trial Details
NCT Number NCT05302375
Lead Sponsor Dartmouth-Hitchcock Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions Cancer, Depression
Enrollment 30 participants
Start Date 2024-07-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-07